Correlation Between Oasmia Pharmaceutical and Pacira BioSciences,

Can any of the company-specific risk be diversified away by investing in both Oasmia Pharmaceutical and Pacira BioSciences, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oasmia Pharmaceutical and Pacira BioSciences, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oasmia Pharmaceutical AB and Pacira BioSciences,, you can compare the effects of market volatilities on Oasmia Pharmaceutical and Pacira BioSciences, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oasmia Pharmaceutical with a short position of Pacira BioSciences,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oasmia Pharmaceutical and Pacira BioSciences,.

Diversification Opportunities for Oasmia Pharmaceutical and Pacira BioSciences,

0.03

Correlation Coefficient

Oasmia Pharmaceutical  Pacira BioSciences,

Significant diversification

The 3 months correlation between Oasmia and Pacira is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Oasmia Pharmaceutical AB and Pacira BioSciences, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pacira BioSciences, and Oasmia Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oasmia Pharmaceutical AB are associated (or correlated) with Pacira BioSciences,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pacira BioSciences, has no effect on the direction of Oasmia Pharmaceutical i.e., Oasmia Pharmaceutical and Pacira BioSciences, go up and down completely randomly.

Pair Corralation between Oasmia Pharmaceutical and Pacira BioSciences,

If you would invest  1,349  in Pacira BioSciences, on September 15, 2024 and sell it today you would earn a total of  637.00  from holding Pacira BioSciences, or generate 47.22% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	1.56%
Values	Daily Returns

Oasmia Pharmaceutical AB  vs.  Pacira BioSciences,

Oasmia Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oasmia Pharmaceutical AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Oasmia Pharmaceutical is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pacira BioSciences,

Risk-Adjusted Performance

17 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Pacira BioSciences, are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Pacira BioSciences, showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Oasmia Pharmaceutical and Pacira BioSciences,

The main advantage of trading using opposite Oasmia Pharmaceutical and Pacira BioSciences, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oasmia Pharmaceutical position performs unexpectedly, Pacira BioSciences, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pacira BioSciences, will offset losses from the drop in Pacira BioSciences,'s long position.

The idea behind Oasmia Pharmaceutical AB and Pacira BioSciences, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.